Imatinib for Multiple Sclerosis (MS) Relapses

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2018
To investigate if treatment with Imatinib results in a better outcome than standard care in form of Methylprednisolone(MP) after MS-associated relapses.
Epistemonikos ID: c3f5e54a578a70df27812fddb24c3087d989adc6
First added on: Mar 31, 2022